anti-Human TNFRSF10D antibody for Immunocytochemistry

The antibodies are intended for use in vitro experiments only. Our antibodies have not been tested nor are recommended for use in vivo.

Gupta, Francis, Nair, Mo, Aggarwal et al.: "Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 ..." in: The Journal of biological chemistry, Vol. 288, Issue 45, pp. 32343-56, 2013 (Sample species: Human). Further details: Western Blotting

Allen, Ferrini, Dicker, Batzer, Chen, Oltean, Lin, Renshaw, Kretz-Rommel, El-Deiry: "Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes." in: Molecular cancer therapeutics, Vol. 11, Issue 10, pp. 2087-95, 2012

Nagane, Shimizu, Mori, Kataoka, Shiokawa: "Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo." in: Neuro-oncology, Vol. 12, Issue 7, pp. 687-700, 2011 (Sample species: Human). Further details: Western Blotting

Zhang, Wang, Liu, Guan, Du: "Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells." in: Endocrine-related cancer, Vol. 15, Issue 2, pp. 535-44, 2008 (Sample species: Human). Further details: Western Blotting

Lunghi, Giuliani, Mazzera, Lombardi, Ricca, Corradi, Cantoni, Salvatore, Riccioni, Costanzo, Testa, Levrero, Rizzoli, Bonati: "Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways." in: Blood, Vol. 112, Issue 6, pp. 2450-62, 2008 (Sample species: Human). Further details: Western Blotting

Taniguchi, Yoshida, Horinaka, Yasuda, Goda, Konishi, Wakada, Kataoka, Yoshikawa, Sakai: "Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells." in: Cancer research, Vol. 68, Issue 21, pp. 8918-27, 2008 Further details: Western Blotting

Kawakubo, Okamoto, Iwata, Shin, Okamoto, Yasukochi, Nakayama, Kadowaki, Tsukuba, Yamamoto: "Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface." in: Cancer research, Vol. 67, Issue 22, pp. 10869-78, 2007 Further details: Western Blotting

Liu, Yue, Khuri, Sun: "Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity." in: Cancer research, Vol. 65, Issue 20, pp. 9169-75, 2005

Poulaki, Mitsiades, McMullan, Fanourakis, Negri, Goudopoulou, Halikias, Voutsinas, Tseleni-Balafouta, Miller, Mitsiades: "Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing." in: Investigative ophthalmology & visual science, Vol. 46, Issue 1, pp. 358-66, 2004

Fan, Zou, Song, Wei: "Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo." in: Cancer chemotherapy and pharmacology, Vol. 55, Issue 2, pp. 189-96, 2004

Koyama et al.: "Flow cytometric measurement of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated ..." in: Journal of gastroenterology and hepatology, Vol. 18, Issue 7, pp. 763-70, 2003 Further details: Flow Cytometry

Mitsiades, Mitsiades, Poulaki, Anderson, Treon: "Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells." in: Blood, Vol. 99, Issue 6, pp. 2162-71, 2002

Poulaki, Mitsiades, Kotoula, Tseleni-Balafouta, Ashkenazi, Koutras, Mitsiades: "Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells." in: The American journal of pathology, Vol. 161, Issue 2, pp. 643-54, 2002

Mitsiades, Mitsiades, Poulaki, Schlossman, Akiyama, Chauhan, Hideshima, Treon, Munshi, Richardson, Anderson: "Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications." in: Oncogene, Vol. 21, Issue 37, pp. 5673-83, 2002 (Sample species: Human). Further details: Cell Sorting

Koyama, Koike, Adachi: "Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor." in: Journal of cancer research and clinical oncology, Vol. 128, Issue 2, pp. 73-9, 2002

Mitsiades, Poulaki, Mitsiades, Tsokos: "Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5." in: Cancer research, Vol. 61, Issue 6, pp. 2704-12, 2001

Mitsiades, Treon, Mitsiades, Shima, Richardson, Schlossman, Hideshima, Anderson: "TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications." in: Blood, Vol. 98, Issue 3, pp. 795-804, 2001

Basile, Zacny, Münger et al.: "The cytokines tumor necrosis factor-alpha (TNF-alpha ) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the ..." in: The Journal of biological chemistry, Vol. 276, Issue 25, pp. 22522-8, 2001 (Sample species: Human). Further details: Western Blotting

Mitsiades, Poulaki, Tseleni-Balafouta, Koutras, Stamenkovic: "Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand." in: Cancer research, Vol. 60, Issue 15, pp. 4122-9, 2000